On the recordJuly 26, 2021
However, an enforcement case would, at the minimum, give us a framework and a timeline to resolve the COFEPRIS-regulated delays in biotechnology approvals.
Source
congress.govEditor's note · Context
Grassley emphasizes the need for enforcement to resolve biotech approval delays.
Share & report
More from Chuck Grassley
Jul 12, 2025
Americans should be grateful that President Trump survived that day and was ultimately reelected to restore common sense to our country.
Jul 1, 2025
Chris Wray’s FBI wasn’t looking out for the American people – it was looking to save its own image.
Aug 25, 2025
A U.S. Atty/district judge nominee without a blue slip does not have the votes to get confirmed on the Senate floor & they don’t have the votes to get out of [committee]. As chairman. I set Pres Trump noms up for SUCCESS NOT FAILURE.
Jul 1, 2025
One way or the other, intelligence must be fully investigated to determine whether it's true, or if it's just smoke and mirrors.
Other voices in this conversation
